241 related articles for article (PubMed ID: 10051540)
21. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide.
Chen G; Shu J; Stacey DW
Oncogene; 1997 Oct; 15(14):1643-51. PubMed ID: 9349497
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism.
Chauhan D; Pandey P; Ogata A; Teoh G; Treon S; Urashima M; Kharbanda S; Anderson KC
Oncogene; 1997 Aug; 15(7):837-43. PubMed ID: 9266970
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
[TBL] [Abstract][Full Text] [Related]
24. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187.
Wang L; Eastmond DA
Environ Mol Mutagen; 2002; 39(4):348-56. PubMed ID: 12112387
[TBL] [Abstract][Full Text] [Related]
25. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
26. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26.
Chen M; Beck WT
Cancer Res; 1995 Apr; 55(7):1509-16. PubMed ID: 7882360
[TBL] [Abstract][Full Text] [Related]
27. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK
Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903
[TBL] [Abstract][Full Text] [Related]
28. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis.
Seimiya H; Mashima T; Toho M; Tsuruo T
J Biol Chem; 1997 Feb; 272(7):4631-6. PubMed ID: 9020192
[TBL] [Abstract][Full Text] [Related]
29. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases.
Juo P; Kuo CJ; Reynolds SE; Konz RF; Raingeaud J; Davis RJ; Biemann HP; Blenis J
Mol Cell Biol; 1997 Jan; 17(1):24-35. PubMed ID: 8972182
[TBL] [Abstract][Full Text] [Related]
30. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells.
Wang L; Roy SK; Eastmond DA
Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356
[TBL] [Abstract][Full Text] [Related]
31. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells.
Shimizu H; Banno Y; Sumi N; Naganawa T; Kitajima Y; Nozawa Y
J Invest Dermatol; 1999 May; 112(5):769-74. PubMed ID: 10233770
[TBL] [Abstract][Full Text] [Related]
32. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53.
Shao RG; Shimizu T; Pommier Y
Exp Cell Res; 1997 Aug; 234(2):388-97. PubMed ID: 9260909
[TBL] [Abstract][Full Text] [Related]
33. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
Anderson H; Roberge M
Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3.
Mo YY; Wang Q; Beck WT
Cancer Res; 1997 Nov; 57(22):5004-8. PubMed ID: 9371492
[TBL] [Abstract][Full Text] [Related]
35. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases.
Toyoshima F; Moriguchi T; Nishida E
J Cell Biol; 1997 Nov; 139(4):1005-15. PubMed ID: 9362518
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha.
McPherson JP; Goldenberg GJ
Cancer Res; 1998 Oct; 58(20):4519-24. PubMed ID: 9788593
[TBL] [Abstract][Full Text] [Related]
37. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford B; Beljin M; Stark GR; Taylor WR
Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
[TBL] [Abstract][Full Text] [Related]
38. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM
Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000
[TBL] [Abstract][Full Text] [Related]
39. The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication.
Pastor N; Domínguez I; Orta ML; Campanella C; Mateos S; Cortés F
Mutat Res; 2012; 738-739():45-51. PubMed ID: 22921906
[TBL] [Abstract][Full Text] [Related]
40. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.
Adjei PN; Kaufmann SH; Leung WY; Mao F; Gores GJ
J Clin Invest; 1996 Dec; 98(11):2588-96. PubMed ID: 8958222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]